(Q34007987)

30 July 2017

Human papillomavirus E7 requires the protease calpain to degrade the retinoblastoma protein (English)

1 reference

30 July 2017

1 reference

9

Andreas Suhrbier

1 reference

30 July 2017

8

Angel Cid-Arregui

1 reference

30 July 2017

6

Joy Gardner

1 reference

30 July 2017

Grant A Darnell

1

1 reference

30 July 2017

Wayne A Schroder

2

1 reference

30 July 2017

Toni M Antalis

3

1 reference

30 July 2017

Eleanore Lambley

4

1 reference

30 July 2017

Lee Major

5

1 reference

30 July 2017

Geoff Birrell

7

1 reference

30 July 2017

language of work or name

English

0 references

publication date

31 October 2007

1 reference

Journal of Biological Chemistry

30 July 2017

1 reference

30 July 2017

282

1 reference

30 July 2017

37492-37500

1 reference

30 July 2017

52

1 reference

Prophylactic human papillomavirus vaccines

30 July 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Pathogenesis of human papillomaviruses in differentiating epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Human papillomavirus immortalization and transformation functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Molecular mechanisms of E2F-dependent activation and pRB-mediated repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Silencing of integrated human papillomavirus type 18 oncogene transcription in cells expressing SerpinB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Calpain inhibition: a therapeutic strategy targeting multiple disease states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Calpain is required for MMP-2 and u-PA expression in SV40 large T-antigen-immortalized cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha/beta priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

MG-132, an inhibitor of proteasomes and calpains, induced inhibition of oocyte maturation and aneuploidy in mouse oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

On the sequential determinants of calpain cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

PEST sequences and regulation by proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

The critical role of calpain versus caspase activation in excitotoxic injury induced by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Management of locally advanced cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706860200

21 January 2018

Identifiers

DOI

10.1074/JBC.M706860200

1 reference

30 July 2017

1 reference